Clinical Trial Update: Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating difluprednate ophthalmic emulsion for anterior uveitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Uveitis

Drugs mentioned

• Durezol (difluprednate)

Snippet

Sponsor: Sirion Therapeutics, Inc. | Conditions: Anterior Uveitis | Phase 2 | Status: COMPLETED